Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
You must be a Standard 1 Year member to access this content.
Lowenstein represented ACA Group in the transaction. ACA Group (ACA), the leading provider of governance, risk, and compliance (GRC) solutions to clients in the financial services...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Pomelo Care in the transaction. Pomelo Care, a virtual medical practice that improves maternal and newborn health outcomes, increases access to care, and...
You must be a Standard 1 Year member to access this content.
Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...
You must be a Standard 1 Year member to access this content.
